You state facts? Like “it’s been 12 weeks since the webinar”? Not so. Scoping study simply is due this quarter. Still 27 days to deliver. I think they will. Too early to whine that it is not yet delivered IMO. What useful purpose does it serve to make your statement other than to unnecessarily criticise the company?
I hope you saw the good post today by @Set. Not hard to see things are on the move towards production.
- Forums
- ASX - By Stock
- RHK
- Up 80% in 1 month
Up 80% in 1 month, page-14
Featured News
Add RHK (ASX) to my watchlist
|
|||||
Last
81.0¢ |
Change
0.010(1.25%) |
Mkt cap ! $161.8M |
Open | High | Low | Value | Volume |
81.0¢ | 81.5¢ | 81.0¢ | $4.191K | 5.166K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5886 | 81.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
82.0¢ | 80 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5886 | 0.810 |
1 | 4430 | 0.800 |
1 | 39473 | 0.760 |
2 | 5573 | 0.740 |
1 | 1309 | 0.700 |
Price($) | Vol. | No. |
---|---|---|
0.820 | 80 | 1 |
0.870 | 1323 | 1 |
0.890 | 2368 | 1 |
0.910 | 20000 | 1 |
0.980 | 10000 | 1 |
Last trade - 15.59pm 03/07/2024 (20 minute delay) ? |
Featured News
RHK (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online